No Data
Hong Kong stock market fluctuation | Ark Pharmacies surged more than 10%, signed a strategic cooperation agreement with Tencent + the market size is expected to continue to expand.
"Mobile medical first stock" JD Health (6086.HK) rose by more than 10%, reaching a high of 7.29 Hong Kong dollars, approaching the historical high of 7.55 Hong Kong dollars set on October 7th.
FANGZHOU JIANKE: 2024 Interim Report
Focus on chronic disease management and technological innovation | The Ark Pharmacist H2H Medical Service Ecosystem Conference was successfully held in Shanghai
Arkindo Health, the "first stock of mobile medical care," held the 9th H2H Medical Service Ecological Conference in Shanghai.
The 'first stock of mobile medical' Fangzhou Jianke reached a strategic cooperation with Tencent, and the strong alliance promotes the digitalization upgrade of digital health.
On September 19, "Mobile Medical First Stock" Ark Pharmacy (06086.HK) held the 9th H2H Medical Services Ecology Conference (hereinafter referred to as the "Ecology Conference") in Shanghai. With the theme of "Smart Medical Innovation Drive", this conference gathered experts from the pharmaceutical industry, well-known domestic and foreign pharmaceutical companies, frontline practitioners, and other guests to share their experiences from different perspectives on topics such as the billion-dollar market of Internet hospitals, efficient operational models of Internet doctors, and digital marketing innovation, providing innovative ideas and inspiration for the industry. Of particular note, at the Ecology Conference, the founder and chairman of Ark Pharmacy, [Name of Founder/Chairman],
Fosun Pharmacy (06086) released its interim performance, with a net loss of 0.819 billion yuan, an increase of 432% year-on-year.
Fangzhou Jianke (06086) announced its six-month performance ending on June 30, 2024, with revenue of 1.323 billion yuan...
Express News | Fangzhou Inc - Revenue Increased by 2.5% to RMB1,322.8 Mln for Six Months
No Data
No Data